Grupo Financiero Galicia S.A. (ADR)  

(Public, NASDAQ:GGAL)   Watch this stock  
Find more results for GGAL
18.70
+0.35 (1.91%)
Jul 2 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 18.20 - 18.87
52 week 10.33 - 26.13
Open 18.43
Vol / Avg. 729,855.00/462,616.00
Mkt cap 2.76B
P/E 6.39
Div/yield 0.09/0.46
EPS 2.93
Shares 1.02B
Beta 1.39
Inst. own 2%

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 20.53% 17.68%
Operating margin 33.68% 27.55%
EBITD margin - 49.08%
Return on average assets 3.73% 3.75%
Return on average equity 35.83% 38.83%
Employees 12,012 -
CDP Score - -

Address

Tte. Gral. Peron 430 25
BUENOS AIRES, CP1038AAJ
Argentina
+54-11-43437528 (Phone)
+54-11-43437528 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Grupo Financiero Galicia S.A. (Grupo Financiero Galicia) is a financial services holding company. Banco de Galicia y Buenos Aires S.A. (Banco Galicia) is the Company’s largest subsidiary. Banco Galicia is a bank that provides, directly or through its subsidiaries, a range of financial products and services to large corporations, small and medium sized companies (SMEs), and individuals. Through the operating subsidiaries of Tarjetas Regionales S.A., a holding company wholly owned by the Bank, the Company provides brand credit cards and consumer finance services throughout Argentina. Through Sudamericana Holding S.A. and its subsidiaries (Sudamericana) it provides insurance products in Argentina. It provides financial services through a distribution platform amongst private-sector financial institutions in Argentina. On April 15, 2014, Banco de Galicia y Buenos Aires SA sold a 95% stake in Galicia Administradora de Fondos to Grupo Financiero Galicia.

Officers and directors

Eduardo J. Escasany Chairman of the Board
Bio & Compensation  - Reuters
Pedro A. Richards Chief Executive Officer
Bio & Compensation  - Reuters
Pablo Gutierrez Vice Chairman of the Board
Bio & Compensation  - Reuters
Jose Luis Gentile Chief Financial Officer
Bio & Compensation  - Reuters
Abel Ayerza Director
Bio & Compensation  - Reuters
Federico Braun Director
Bio & Compensation  - Reuters
Juan Miguel Cuattromo Director
Bio & Compensation  - Reuters
Antonio Roberto Garces Director
Bio & Compensation  - Reuters
C. Enrique Martin Director
Bio & Compensation  - Reuters